Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor X Deficiency”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Large-scale testing (Phase 3)Study completedNCT02526160
What this trial is testing

Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin, Inc. 134
Large-scale testing (Phase 3)Study completedNCT00930176
What this trial is testing

A Study Investigating Treatment Factor X in People With Factor X Deficiency

Who this might be right for
Factor X Deficiency
Bio Products Laboratory 16
Not applicableStudy completedNCT02190149
What this trial is testing

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 64
Not applicableEnded earlyNCT02402829
What this trial is testing

A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture

Who this might be right for
Hemophilia AFactor VIII DeficiencyHemophilia+2 more
Children's Mercy Hospital Kansas City 3
Large-scale testing (Phase 3)Looking for participantsNCT06963216
What this trial is testing

A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

Who this might be right for
Acquired Factor X Deficiency
Kedrion S.p.A. 15
Early research (Phase 1)Looking for participantsNCT06349473
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

Who this might be right for
Healthy ParticipantsHemophilia AHemophilia B+1 more
Equilibra Bioscience LLC 36
Large-scale testing (Phase 3)Study completedNCT02537431
What this trial is testing

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin, Inc. 14
Not applicableStudy completedNCT04429568
What this trial is testing

THC Crossover Study

Who this might be right for
THCCannabisCannabis Smoking+6 more
University of California, San Francisco 14
Post-approval studies (Phase 4)UnknownNCT04419363
What this trial is testing

Burosumab in Children and Adolescents With X-linked Hypophosphatemia

Who this might be right for
Rare DiseasesX-linked Hypophosphatemia
Bicetre Hospital 57
Testing effectiveness (Phase 2)Study completedNCT03734588
What this trial is testing

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

Who this might be right for
Adeno-Associated Virus (AAV)Blood Coagulation DisorderBlood Coagulation Disorders, Inherited+14 more
Spark Therapeutics, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT02163577
What this trial is testing

Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin, Inc. 52
Post-approval studies (Phase 4)Study completedNCT01988662
What this trial is testing

UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)

Who this might be right for
Neovacular Age-related Macular Degeneration
Novartis Pharmaceuticals 205
Post-approval studies (Phase 4)Study completedNCT00002386
What this trial is testing

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
Merck Sharp & Dohme LLC 55
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT01687608
What this trial is testing

Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Testing effectiveness (Phase 2)Study completedNCT03003533
What this trial is testing

A Gene Transfer Study for Hemophilia A

Who this might be right for
Hemophilia A
Spark Therapeutics, Inc. 25
Testing effectiveness (Phase 2)Ended earlyNCT00490100
What this trial is testing

Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1

Who this might be right for
Growth FailureX-linked Severe Combined Immunodeficiency (XSCID)Growth Hormone Resistence
National Institute of Allergy and Infectious Diseases (NIAID) 6
Testing effectiveness (Phase 2)Study completedNCT00004801
What this trial is testing

Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency

Who this might be right for
Hemophilia BFactor IX Deficiency
National Center for Research Resources (NCRR) 3
Not applicableUnknownNCT06014320
What this trial is testing

Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease

Who this might be right for
Liver CirrhosisHemophiliaHemophilia A+4 more
Stanford University 25
Testing effectiveness (Phase 2)Study completedNCT00004787
What this trial is testing

Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes

Who this might be right for
Shwachman SyndromeFanconi's AnemiaDyskeratosis Congenita+1 more
National Center for Research Resources (NCRR) 20
Load More Results